Cargando…
Long-term efficacy of IL-1 blockers in PAPA patients
Autores principales: | Finetti, M, Caorsi, R, Marotto, D, Buoncompagni, A, Omenetti, A, Lattanzi, B, Minoia, F, Picco, P, Jorini, M, Martini, A, Gattorno, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599684/ http://dx.doi.org/10.1186/1546-0096-13-S1-P207 |
Ejemplares similares
-
Long-term efficacy of etanercept in ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2014) -
PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
por: Omenetti, A, et al.
Publicado: (2013) -
PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013) -
Chronic active EBV infection mimicking periodic fever syndromes: a new challenge for the paediatrician
por: Caorsi, Roberta, et al.
Publicado: (2014) -
PReS-FINAL-2238: PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome: results from the Eurofever registry
por: Caorsi, R, et al.
Publicado: (2013)